期刊文献+

加替沙星治疗社区获得性肺炎疗效观察 被引量:5

Observation of the therapeutic effects of gatifloxacin on community acquired pneumonia
下载PDF
导出
摘要 目的探讨加替沙星治疗社区获得性肺炎的疗效及不良反应的发生。方法入选2005年2月1日至2006年1月31日我医院的CAP住院患者107例,随机分成A、B两组。A组(54例)给予生理盐水250ml+加替沙星400mg静脉滴注,qd,治疗14d;B组(53例)给予生理盐水100ml+头孢呋辛2.0g静脉滴注,q12h,治疗14d。依据症状、体征、实验室检查恢复以及致病菌清除评价疗效;依据治疗前后肝、肾功能、血糖改变及恶心、呕吐消化道反应发生率评价不良反应。结果两组治愈率分别为57.4%和54.7%,通过Ridit检验,统计学无显著性差异;有效率分别为94.4%和88.7%,有显著性差异(P<0.05);两组细菌清除率分别为88.9%和94.1%,无显著性差异(P>0.05)。两组治疗前后肝、肾功能、血糖改变及恶心、呕吐消化道反应发生率均无统计学差异。结论应用加替沙星治疗CAP,能达到非常满意的临床效果与满意的细菌清除率,且不良反应发生率低,值得临床推广。 Objective To investigate the efficacy and adverse effects of gatifloxacin on community acquied pneumonia (CAP). Methods One hundred and seven cases of CAP hospitalized patients were selected from the Fifth Affiliated Hospital of Zhengzhou University, from 1st Feb, 2005 to 31st Jan, 2006. They were randomly divided into group A and B. Group A (54cases), were treated with normal saline (250ml) and gatifioxacin (400mg) intravenous drip per day for 14 days; Group B (53cases), were treated with normal saline (100ml) and cefuroxime (2.0g) intravenous drip per 12 hours for 14 days. The efficacies were evaluated according to the therapeutic indices, including symptom, sign, recovery of laboratory examination and clear- ance rate of pathogenic bacteria and the adverse reaction indices, including the shift of liver, renal functions and blood sugar pre/post-treatment, the occurrence of alimentary tract reactions such as nausea, vomiting. Results For gatifloxacin and cefuroxime, the cure rate of CAP were 57.4% and 54.7% respectively, there was no significant difference with Ridit test. The efficacy rates were 94.4% and 88.7% respectively with significant differences (P〈0. 05). The clearance rate of pathogenic bacteria were 88.9% and 94.1% respectively (P〉0.05). No statistic difference was shown between the two groups for adverse reactions. Conclusion Satisfactory clinical efficacies and clearance of pathogens can be achieved with gatifloxacin therapy of CAP with low ADR occurrence. Gatifloxacin could be used for clinical CAP treatment.
出处 《中国抗生素杂志》 CAS CSCD 北大核心 2007年第5期313-315,共3页 Chinese Journal of Antibiotics
关键词 加替沙星 社区获得性肺炎 临床疗效 细菌清除率 Gatifloxacin Community acquired pneumonia Clinical therapeutic effects Clearance of pathogens
  • 相关文献

参考文献10

二级参考文献41

  • 1李家泰.临床毒理学与药物评价[J].中国临床药理学杂志,1994,10(3):184-188. 被引量:37
  • 2Ngeow YF,Suwanjutha S,Chantarojanasriri T,et al.An asian study on the prevalence of atypical respiratory pathogens in community-acquired pneumonia.Int J Infect Dis,2005,9:144-153. 被引量:1
  • 3Lepow ML,Balassanian N,Emmerich J,et al.Interrelationships of viral,mycoplasmal,and bacterial agents in uncomplicated pneumonia.Am Rev Respir Dis,1968,97:533-545. 被引量:1
  • 4Lim WS,Macfarlane JT,Boswell TC,et al.Study of community acquired pneumonia aetiology(SCAPA) in adults admitted to hospital:implications for management guidelines.Thorax,2001,56:296-301. 被引量:1
  • 5Niederman MS,Mandell LA,Anzueto A,et al.Guidelines for the management of adults with community-acquired pneumonia.Diagnosis,assessment of severity,antimicrobial therapy,and prevention.Am J Respir Crit Care Med,2001,163:1730-1754. 被引量:1
  • 6Heffelfinger JD,Dowell SF,Jorgensen JH,et al.Management of community-acquired pneumonia in the era of pneumococcal resistance:a report from the Drug-Resistant Streptococcus pneumoniae Therapeutic Working Group.Arch Intern Med,2000,160:1399-1408. 被引量:1
  • 7Lu T, Zhao X L, Drlica K, et al. Gatifloxacin activity against quinolone-resistan gyrase., allele-specific enhancement of bacteriostatic and bactericidal activities by the C-8-methoxy group [J]. Antimicrob Agents Chemother,1999,43(12):2969. 被引量:1
  • 8Tarshis G A, Miskin B M, Jona T M, et al. Once-daily oral gatifloxacin versus oral levofloxacin in treatment of uncomplicated skin and soft tissue Infections: doubleblind, multicenter randomized study [J]. Antimicrob Agents Chemother , 2001,4 5 ( 8 ) : 2358. 被引量:1
  • 9Brown-Elliott B A, Wallace R J, Crist C J, et al. Comparison of in vitro activities of gatifloxacin and ciprofloxacin against four taxa of rapidly growing mycobacteria[J]. Antimicrob Agents Chemother, 2002,46(10) : 3283. 被引量:1
  • 10Brown-Elliott B A, Wallace R J. Pharmacodynamic assessment of gatifloxacin against Streptococcus pneumoniae[J]. Antimicrob Agents Chemother, 2002,46 (10) : 2092. 被引量:1

共引文献1796

同被引文献24

引证文献5

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部